However, the limited therapeutic efficacy of using anti-TNF-α therapies for improving obesity-induced insulin resistance and glucose metabolism suggests that macrophages in adipose tissue may also influence metabolic status through other pathways. The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.